Aiforia Technologies Plc reinforces its Management Team to accelerate the implementation of the company's growth strategy. Thomas Westerling-Bui has, as of October 14th 2022, been appointed as Chief Commercial Officer of Americas and as a member of the Management Team (previously Vice President of AI Solutions & Strategy). Thomas joined Aiforia in 2018 and has been instrumental in establishing the US subsidiary and strengthening Aiforia's position in the market.

Thomas received his Ph.D. with honors from the University of Helsinki Medical School. He went on to do research, supported by an EMBO long-term fellowship at the Dana Farber Cancer Institute and Harvard Medical School in Boston. His fellowship focused on understanding the effects of epigenetic and genomic factors on breast cancer, prostate cancer, and drug resistance.

Thomas was accepted into the MIT Sloan Executive MBA program in 2022. After the appointment, the composition of Aiforia's Management Team is as follows: Jukka Tapaninen, Chief Executive Officer, Kaisa Helminen, Chief Operating Officer, Veli-Matti Parkkonen, Chief Financial Officer, Kari Pitkänen, Director of Business Development, Tuomas Ropponen, Chief Technology Officer, Thomas Westerling-Bui, Chief Commercial Officer, Americas.